Income Statement Ultimovacs ASA OTC Markets

Stocks

ULTMF

NO0010851603

Delayed OTC Markets Other stock markets 20:10:00 2024-01-24 EST			5-day change	1st Jan Change
13.33 ^USD	-.--%		-.--%	-

25-03-30	Ultimovacs ASA(OB:ULTI) dropped from Next Biotech Index	CI
25-03-04	Ultimovacs ASA will Change its Name to Zelluna ASA	CI

dfa5c6946c1f3a0c04097713629d.G7rc9MQCI7nUa1XtmgeuzWwM1mauwPVN36ZfVESqTas.Q8imxadpEdemOA2jq0PNtTV4tVbHjYM57NQQJT3uPect6LC_o0xXzIYdFA

Published financial data: ULTIMOVACS ASA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Selling General & Admin Expenses, Total	37.27M	55.98M	56.84M	61.49M	53.88M
Depreciation & Amortization - (IS)	2.72M	2.7M	2.65M	2.77M	2.77M
Other Operating Expenses	79.16M	105M	120M	151M	94.61M
Other Operating Expenses, Total	119M	164M	179M	216M	151M
Operating Income	-119M	-164M	-179M	-216M	-151M
Interest Expense, Total	-240K	-333K	-243K	-382K	-299K
Interest And Investment Income	4.58M	3.06M	8.91M	14.13M	8.6M
Net Interest Expenses	4.34M	2.73M	8.66M	13.74M	8.3M
Currency Exchange Gains (Loss)	-747K	-3.62M	7.18M	12.75M	2.73M
Other Non Operating Income (Expenses)	2K	-1K	-	-1K	-1K
EBT, Excl. Unusual Items	-116M	-165M	-163M	-189M	-140M
Impairment of Goodwill	-	-	-	-	-72.49M
Other Unusual Items	-5M	-	-4.5M	-	-
EBT, Incl. Unusual Items	-121M	-165M	-168M	-189M	-213M
Income Tax Expense	-	-	-	-	-11.65M
Earnings From Continuing Operations	-121M	-165M	-168M	-189M	-201M
Net Income to Company	-121M	-165M	-168M	-189M	-201M
Net Income - (IS)	-121M	-165M	-168M	-189M	-201M
Net Income to Common Incl Extra Items	-121M	-165M	-168M	-189M	-201M
Net Income to Common Excl. Extra Items	-121M	-165M	-168M	-189M	-201M
Per Share Items
Net EPS - Basic	-39.84	-50.88	-48.99	-55.01	-58.44
Basic EPS - Continuing Operations	-39.84	-50.88	-48.99	-55.01	-58.44
Basic Weighted Average Shares Outstanding	3.03M	3.24M	3.42M	3.44M	3.44M
Net EPS - Diluted	-39.84	-50.88	-48.99	-55.01	-58.44
Diluted EPS - Continuing Operations	-39.84	-50.88	-48.99	-55.01	-58.44
Diluted Weighted Average Shares Outstanding	3.03M	3.24M	3.42M	3.44M	3.44M
Normalized Basic EPS	-23.87	-31.8	-29.8	-34.38	-25.47
Normalized Diluted EPS	-23.87	-31.8	-29.8	-34.38	-25.47
Supplemental Items
EBITDA	-118M	-163M	-178M	-215M	-150M
EBITA	-119M	-163M	-178M	-215M	-151M
EBIT	-119M	-164M	-179M	-216M	-151M
EBITDAR	-118M	-162M	-177M	-214M	-149M
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	-	-	-	-	5.48
Normalized Net Income	-72.22M	-103M	-102M	-118M	-87.64M
Interest on Long-Term Debt	240K	333K	243K	382K	299K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	64.66M	96.74M	95.18M	124M	88.68M
Net Rental Expense, Total	579K	754K	1.03M	1.25M	1.35M
Imputed Operating Lease Interest Expense	300K	685K	529K	833K	1.11M
Imputed Operating Lease Depreciation	279K	69.27K	500K	420K	237K
Stock-Based Comp., SG&A Exp. (Total)	6.78M	11.6M	20.4M	14.26M	4.34M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	6.78M	11.6M	20.4M	14.26M	4.34M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	441M	574M	425M	267M	107M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	441M	574M	425M	267M	107M
Other Receivables	7.69M	6.45M	6.27M	4.09M	4.36M
Total Receivables	7.69M	6.45M	6.27M	4.09M	4.36M
Prepaid Expenses	748K	878K	2.92M	1.46M	2.11M
Other Current Assets, Total	-	759K	1.08M	1K	-
Total Current Assets	449M	582M	436M	272M	114M
Gross Property Plant And Equipment	5.69M	4.1M	7.79M	5.93M	4.37M
Accumulated Depreciation	-1.69M	-1.94M	-2.12M	-2.26M	-2.36M
Net Property Plant And Equipment	4.01M	2.16M	5.66M	3.68M	2.02M
Goodwill	11.8M	11.03M	10.7M	11.65M	-
Other Intangibles, Total	64.55M	60.09M	57.73M	61.6M	-
Other Long-Term Assets, Total	1K	-	-	-2K	-
Total Assets	530M	656M	510M	349M	116M
Liabilities
Accounts Payable, Total	8.61M	22.56M	7.66M	11.17M	4.82M
Accrued Expenses, Total	17.15M	26.71M	36.48M	38.23M	24.8M
Short-term Borrowings	-	-	-	-	-
Current Portion of Leases	1.71M	1.63M	1.77M	1.83M	1.86M
Current Income Taxes Payable	-	-	-	-	-
Other Current Liabilities	-	-	-	4.88M	-
Total Current Liabilities	27.47M	50.9M	45.91M	56.11M	31.48M
Long-Term Leases	2.08M	457K	3.71M	1.89M	230K
Deferred Tax Liability Non Current	11.8M	11.03M	10.7M	11.65M	-
Other Non Current Liabilities	-	-	1K	-	1.48M
Total Liabilities	41.34M	62.38M	60.32M	69.65M	33.19M
Common Stock, Total	3.2M	3.42M	3.44M	3.44M	3.44M
Additional Paid In Capital	809M	1.07B	1.08B	1.08B	14.19M
Retained Earnings	-340M	-504M	-672M	-861M	-
Comprehensive Income and Other	15.57M	23.21M	41.72M	60.7M	65.03M
Total Common Equity	488M	593M	449M	279M	82.67M
Total Equity	488M	593M	449M	279M	82.67M
Total Liabilities And Equity	530M	656M	510M	349M	116M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.2M	3.42M	3.44M	3.44M	3.44M
ECS Total Common Shares Outstanding	3.2M	3.42M	3.44M	3.44M	3.44M
Book Value / Share	152.75	173.33	130.64	81.2	24.03
Tangible Book Value	412M	522M	381M	206M	82.67M
Tangible Book Value Per Share	128.87	152.54	110.74	59.91	24.03
Total Debt	3.78M	2.08M	5.48M	3.71M	2.09M
Net Debt	-437M	-572M	-420M	-263M	-105M
Debt Equivalent Oper. Leases	4.63M	6.03M	8.23M	10.02M	10.78M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	2.06M	2.15M	2.34M	2.37M	2.38M
Full Time Employees	18	22	22	24	12
Part Time Employees	3	3	3	3	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-121M	-165M	-168M	-189M	-201M
Depreciation & Amortization - CF	2.17M	1.95M	1.89M	2.01M	2.02M
Amortization of Goodwill and Intangible Assets - (CF)	551K	754K	754K	754K	754K
Depreciation & Amortization, Total	2.72M	2.7M	2.65M	2.77M	2.77M
Asset Writedown & Restructuring Costs	-	-	-	-	72.49M
Stock-Based Compensation (CF)	6.78M	11.6M	20.4M	14.26M	4.34M
Other Operating Activities, Total	-3.56M	736K	-15.96M	-26.5M	-22.73M
Change In Accounts Payable	6.83M	23.51M	-5.13M	5.26M	-18.3M
Change in Other Net Operating Assets	-433K	351K	-1.86M	3.63M	-918K
Cash from Operations	-108M	-126M	-168M	-190M	-163M
Capital Expenditure	-282K	-85K	-195K	-25K	-17K
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-5M	-	-	-	-
Other Investing Activities, Total	4.55M	3.06M	8.89M	14.06M	8.6M
Cash from Investing	-736K	2.98M	8.69M	14.03M	8.58M
Long-Term Debt Repaid, Total	-1.68M	-1.72M	-1.8M	-1.77M	-1.96M
Total Debt Repaid	-1.68M	-1.72M	-1.8M	-1.77M	-1.96M
Issuance of Common Stock	160M	273M	5.48M	300K	-
Other Financing Activities, Total	-7.3M	-11.19M	-105K	-380K	-257K
Cash from Financing	151M	260M	3.58M	-1.85M	-2.22M
Foreign Exchange Rate Adjustments	-739K	-3.86M	6.57M	18.89M	-2.15M
Miscellaneous Cash Flow Adjustments	-	-	1K	-	-
Net Change in Cash	41.32M	133M	-149M	-159M	-159M
Supplemental Items
Cash Interest Paid	236K	179K	105K	380K	257K
Levered Free Cash Flow	-64.01M	-64.53M	-96.57M	-103M	-113M
Unlevered Free Cash Flow	-63.86M	-64.32M	-96.42M	-103M	-113M
Change In Net Working Capital	-6.39M	-23.86M	7.31M	-14.85M	25.58M
Net Debt Issued / Repaid	-1.68M	-1.72M	-1.8M	-1.77M	-1.96M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-14.78	-17.28	-19.22	-31.4	-40.67
Return on Total Capital	-15.84	-18.83	-21.32	-36.54	-51.4
Return On Equity %	-25.84	-30.46	-32.19	-51.94	-111.06
Return on Common Equity	-25.84	-30.46	-32.19	-51.94	-111.06
Short Term Liquidity
Current Ratio	16.36	11.44	9.49	4.85	3.62
Quick Ratio	16.33	11.41	9.4	4.82	3.55
Operating Cash Flow to Current Liabilities	-3.94	-2.47	-3.65	-3.38	-5.19
Long Term Solvency
Total Debt/Equity	0.77	0.35	1.22	1.33	2.53
Total Debt / Total Capital	0.77	0.35	1.2	1.31	2.47
LT Debt/Equity	0.42	0.08	0.83	0.68	0.28
Long-Term Debt / Total Capital	0.42	0.08	0.82	0.67	0.27
Total Liabilities / Total Assets	7.8	9.52	11.84	19.95	28.65
EBIT / Interest Expense	-496.45	-491.99	-737.16	-564.75	-505.88
EBITDA / Interest Expense	-485.11	-483.87	-726.27	-557.51	-496.62
(EBITDA - Capex) / Interest Expense	-486.29	-484.13	-727.07	-557.57	-496.67
Total Debt / EBITDA	-0.03	-0.01	-0.03	-0.02	-0.01
Net Debt / EBITDA	3.75	3.55	2.38	1.23	0.71
Total Debt / (EBITDA - Capex)	-0.03	-0.01	-0.03	-0.02	-0.01
Net Debt / (EBITDA - Capex)	3.75	3.55	2.38	1.23	0.71
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	80.17	32.21	9.43	20.57	-30
EBITA, 1 Yr. Growth %	79.82	31.94	9.38	20.52	-29.99
EBIT, 1 Yr. Growth %	79.93	31.97	9.34	20.43	-29.89
Earnings From Cont. Operations, 1 Yr. Growth %	97.09	36.64	1.86	12.78	6.25
Net Income, 1 Yr. Growth %	97.09	36.64	1.86	12.78	6.25
Normalized Net Income, 1 Yr. Growth %	88.92	36.64	-0.87	15.89	-25.9
Diluted EPS Before Extra, 1 Yr. Growth %	49.33	27.72	-3.71	12.29	6.22
Net Property, Plant and Equip., 1 Yr. Growth %	-1.28	-46.02	161.86	-35.12	-45.14
Total Assets, 1 Yr. Growth %	10.81	23.75	-22.25	-31.52	-66.81
Tangible Book Value, 1 Yr. Growth %	8.93	26.7	-27.03	-45.88	-59.9
Common Equity, 1 Yr. Growth %	9.84	21.45	-24.24	-37.82	-70.41
Cash From Operations, 1 Yr. Growth %	71.81	16.27	33.27	13.2	-13.92
Capital Expenditures, 1 Yr. Growth %	63.95	-69.86	129.41	-87.18	-32
Levered Free Cash Flow, 1 Yr. Growth %	28.67	-3.88	49.66	6.88	9.68
Unlevered Free Cash Flow, 1 Yr. Growth %	28.8	-3.97	49.9	6.8	9.75
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	45.36	57.57	20.28	14.87	-8.13
EBITA, 2 Yr. CAGR %	45.19	57.25	20.13	14.82	-8.14
EBIT, 2 Yr. CAGR %	45.19	57.29	20.12	14.75	-8.11
Earnings From Cont. Operations, 2 Yr. CAGR %	47.67	64.1	17.98	7.18	9.47
Net Income, 2 Yr. CAGR %	47.67	64.1	17.98	7.18	9.47
Normalized Net Income, 2 Yr. CAGR %	44.58	64.1	16.38	7.18	-7.33
Diluted EPS Before Extra, 2 Yr. CAGR %	5.99	38.1	10.9	3.98	9.21
Net Property, Plant and Equip., 2 Yr. CAGR %	133.33	-27	18.89	30.35	-40.34
Total Assets, 2 Yr. CAGR %	67.03	17.1	-1.91	-27.03	-52.32
Tangible Book Value, 2 Yr. CAGR %	111.05	17.48	-3.85	-37.16	-53.41
Common Equity, 2 Yr. CAGR %	74.76	15.5	-4.08	-31.37	-57.11
Cash From Operations, 2 Yr. CAGR %	46.55	41.34	24.48	22.83	-1.29
Capital Expenditures, 2 Yr. CAGR %	-25.86	-29.7	-16.84	-45.77	-70.47
Levered Free Cash Flow, 2 Yr. CAGR %	62.04	13.9	19.94	26.47	8.27
Unlevered Free Cash Flow, 2 Yr. CAGR %	62.12	13.9	19.98	26.53	8.27
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	53.2	42.8	39.54	20.38	-2.61
EBITA, 3 Yr. CAGR %	52.98	42.59	39.33	20.26	-2.64
EBIT, 3 Yr. CAGR %	52.81	42.58	39.34	20.22	-2.63
Earnings From Cont. Operations, 3 Yr. CAGR %	54.28	43.9	39.99	16.22	6.87
Net Income, 3 Yr. CAGR %	54.28	43.9	39.99	16.22	6.87
Normalized Net Income, 3 Yr. CAGR %	52.11	43.9	38.72	16.22	-5.23
Diluted EPS Before Extra, 3 Yr. CAGR %	16.91	12.79	22.46	11.36	4.72
Net Property, Plant and Equip., 3 Yr. CAGR %	92.93	43.24	11.75	-2.84	-2.32
Total Assets, 3 Yr. CAGR %	43.62	51.14	2.16	-12.98	-43.88
Tangible Book Value, 3 Yr. CAGR %	36.19	78.04	0.23	-20.61	-45.9
Common Equity, 3 Yr. CAGR %	43.15	54.8	0.35	-16.99	-48.15
Cash From Operations, 3 Yr. CAGR %	58.41	35.67	38.6	20.6	9.1
Capital Expenditures, 3 Yr. CAGR %	137.69	-45.08	4.27	-55.41	-41.52
Levered Free Cash Flow, 3 Yr. CAGR %	63.2	38.33	24.75	15.42	20.61
Unlevered Free Cash Flow, 3 Yr. CAGR %	63.07	38.34	24.82	15.42	20.67
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	41.31	41.51	40.23	30.89	18.06
EBITA, 5 Yr. CAGR %	41.23	41.34	40.04	30.75	17.94
EBIT, 5 Yr. CAGR %	41.36	41.21	39.93	30.72	17.96
Earnings From Cont. Operations, 5 Yr. CAGR %	42.27	41.56	38.58	27.91	26.87
Net Income, 5 Yr. CAGR %	42.27	41.56	38.58	27.91	26.87
Normalized Net Income, 5 Yr. CAGR %	41.07	41.56	37.83	27.91	18.05
Diluted EPS Before Extra, 5 Yr. CAGR %	-	15.31	14.47	9.18	16.98
Net Property, Plant and Equip., 5 Yr. CAGR %	75.91	21.92	58.96	37.94	-13.06
Total Assets, 5 Yr. CAGR %	68.09	51.32	23.3	12.95	-24.68
Tangible Book Value, 5 Yr. CAGR %	72.43	48.55	18.49	17.38	-26.22
Common Equity, 5 Yr. CAGR %	73.63	50.9	21.97	11.81	-28.57
Cash From Operations, 5 Yr. CAGR %	-	32.25	43.85	30.38	21
Capital Expenditures, 5 Yr. CAGR %	-	-35.94	56.16	-45.35	-37.05
Levered Free Cash Flow, 5 Yr. CAGR %	-	28.5	45.67	33.46	17.88
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	28.41	45.62	33.49	17.92